Luteolin alleviates LPS-induced gut dysbiosis in mice

This study investigates the potential of luteolin to modulate the gut microbiota in an inflammatory setting. We induced systemic inflammation in mice using lipopolysaccharide (LPS) and subsequently administered luteolin to assess its anti-inflammatory effects on the gut microbiome.